Improved Treatment Alternative For Lymphoid Leukemia Suggested By International Study
2/13/2013
Discovering what they call the "Achilles' heel" for lymphoid leukemia, an international research team has tested a possible alternative treatment that eradicated the disease in mouse models...
Factors For Eradicating Gastric Cancer Causing Bacterium H Pylori
2/13/2013
The bacterium Helicobacter pylori is one of the leading causes of gastric cancer worldwide, researchers analyzed the results of interventions that tried to eradicate the bacterium in several different Latin American population groups...
Improved Understanding Of Clear Cell Sarcoma Offered By Mouse Model
2/13/2013
Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises. The mouse model also can potentially speed the development of drugs to target genes that must be activated for the cancer to form...
Patient Safety Improved By Comprehensive Maternal Hemorrhage Protocols
2/13/2013
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting ™, in San Francisco, researchers will report findings that suggest comprehensive maternal hemorrhage protocols reduce utilization of blood products and improve patient safety...
Genetic Root To Early-Onset Prostate Cancer Identified
2/13/2013
Prostate cancer is often considered an elderly man's disease, and little is known about the approximately 2% of cases that arise in men who are aged 50 years or younger. Research published in Cell Press journal Cancer Cell uncovers the genetic origin of such early-onset prostate cancer...
Improved Treatment Alternative For Lymphoid Leukemia Suggested By International Study
2/13/2013
Discovering what they call the "Achilles' heel" for lymphoid leukemia, an international research team has tested a possible alternative treatment that eradicated the disease in mouse models...
Patient Safety Improved By Comprehensive Maternal Hemorrhage Protocols
2/13/2013
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting ™, in San Francisco, researchers will report findings that suggest comprehensive maternal hemorrhage protocols reduce utilization of blood products and improve patient safety...
In Ovarian Cancer MiR-506 Works By Blocking Epithelial-To-Mesenchymal Cell Transition
2/12/2013
Researchers employed an extensive analysis of genomic information to identify a new, high-risk cohort of ovarian cancer patients, characterize their tumors, find a potential treatment and test it in mouse models of the disease...
In Ovarian Cancer MiR-506 Works By Blocking Epithelial-To-Mesenchymal Cell Transition
2/12/2013
Researchers employed an extensive analysis of genomic information to identify a new, high-risk cohort of ovarian cancer patients, characterize their tumors, find a potential treatment and test it in mouse models of the disease...
Tumour Blood Vessels Prevent The Spread Of Cancer Cells
2/12/2013
A lack of the protein endoglin in the blood vessels of tumour-bearing mice enables the spread of daughter tumours, according to researchers at Karolinska Institutet and Lund University, Sweden, in a study published in the scientific periodical The Journal of Experimental Medicine...